Sao Joao University Hospital Center — Clinical Trial Site

21 Registered trials

1 Currently recruiting

Organisation

Sao Joao University Hospital Center

Location

Porto, Portugal

Identifier

ORG-100033185

Address

Alameda Professor Hernani Monteiro, 4200-319, Portugal

Departments

3102:Medicina Interna
Cardiology
Centro Hospitalar Universitario S. Joao EPE
Departamento de Cardiologia Pediátrica
Dermatology
Endocrinology Department
Infectious Diseases
Intensive Care Unit
Internal Medicine department
Medical Oncology
N/A
NA
Nephrology
Oncology
Ophtalmology
Ophthalmology
Serviço de Cardiologia Pediátrica
Urology

Clinical trials at this site (21)

Search interface

Phase 3 Study Assessing Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit) Not authorised

2022-501535-16-00 Atopic Dermatitis (AD) 5
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) Recruiting

2022-502415-11-00 Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) 5 2023-06-16
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF Ended

2025-520809-12-00 Diabetic Macular Edema 10 2025-10-16
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Ended

2022-502779-40-00 Primary prevention of atherosclerotic cardiovascular di 5 2023-09-04
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Ended

2022-501024-20-00 ER+/HER2- Early Breast Cancer 5 2023-07-25
A study of safety and efficacy of NBI-74788 in Classic Congenital Adrenal Hyperplasia Ended

2023-509171-16-00 Classic Congenital Adrenal Hyperplasia (CAH) 5 2020-11-23
Parent and/or Legal Guardian ICF and Adult patient ICF: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study wi… Ended

2022-501012-34-00 Pulmonary Arterial Hypertension 5 2020-02-27
Chemotherapy-free trastuzumab and pertuzumab in HER2-positive breast cancer after FDG-PET response-adapted strategy. The PHERGain study Ended

2023-509923-42-00 HER2- positive breast cancer 4 2017-07-06
Open-label Extension of Vericiguat in Pediatric Participants with Heart Failure due to Left Ventricular Systolic Dysfunction Ended

2023-506210-40-00 Heart Failure due to Systemic Left Ventricular Systolic 5 2024-06-28
A study to learn how well a higher amount of aflibercept given as an injection into the eye works and how safe it is in people with reduced … Ended

2022-502174-16-00 Macular edema secondary to retinal vein occlusion 5 2023-09-13
A study to evaluate Intravitreal JNJ-81201887(AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary… Ended

2022-500746-16-00 Geographic Atrophy 4 2023-08-11
Initiation of angiotensin receptor-neprilysin inhibitor (ARNi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with heart… Ended

2022-502409-14-00 Heart failure with reduced ejection fraction 11 2023-08-04
Overactive Bladder Treatment with Xeomin and Vibe Delivery System (XAVIER) Ended

2022-501759-95-00 Overactive bladder (OAB) 4 2023-06-05
This is a study to evaluate dose-flexibility of Upadacitinib in Adult Subjects with Moderate to Severe Atopic Dermatitis Ended

2023-504869-23-00 Dermatitis atopic 11 2023-05-31
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe AD (ROCKET-Horizon) Ended

2022-501538-44-00 Atopic Dermatitis 5 2023-04-25
VISIONARY Trial: Phase 3 Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN) Ended

2022-500079-30-00 IgA Nephropathy 5 2022-11-03
Cohort study of human mpox virus disease Ended

2022-501132-42-00 Monkeypox virus disease 6 2022-08-02
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct) Ended

2022-500385-99-00 SARS-CoV II infection (Coronavirus disease) 5 2021-06-03
Study to assess the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab in chronic obstructive pulmonary disease (COPD) (AER… Ended

2024-512012-21-00 Chronic Obstructive Pulmonary Disease 5 2021-04-08
Evaluation of Upadacitinib in Adolescent and Adult Patients with Moderate to Severe Atopic Dermatitis (Eczema) – Measure Up 2 Ended

2022-502936-38-00 Moderate and Severe Atopic Dermatitis 5 2019-01-09